Stocks and InvestingStocks and Investing
Thu, March 24, 2022
Wed, March 23, 2022
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022

William Plovanic Maintained (TMDX) at Strong Buy with Increased Target to $39 on, Mar 17th, 2022


Published on 2024-10-27 20:07:29 - WOPRAI, William Plovanic
  Print publication without navigation


William Plovanic of Canaccord Genuity, Maintained "TransMedics Group, Inc." (TMDX) at Strong Buy with Increased Target from $38 to $39 on, Mar 17th, 2022.

William has made no other calls on TMDX in the last 4 months.



There is 1 other peer that has a rating on TMDX. Out of the 1 peers that are also analyzing TMDX, all agrees with William's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, February 25th, 2022